DRUG · Unmapped registry intervention
Nivolumab or Pembrolizumab or Atezolizumab
Find medicine records ·
Find other trials using this name
Clinical trial
CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid Tumors
NCT03511391
Study summary
ClinicalTrials.govCHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid Tumors
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
RADIATION · Unmapped registry intervention
SBRT
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Interventions
SBRTRADIATION
Sponsors & collaborators
University Hospital, Ghentlead sponsor
GZA Ziekenhuizen Campus Sint-Augustinuscollaborator
AZ Sint-Lucas Bruggecollaborator
Jules Bordet Institutecollaborator
AZ Sint-Lucas Gentcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03511391 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.